<DOC>
	<DOCNO>NCT00328705</DOCNO>
	<brief_summary>This acute , prospective , multi-center , non-randomized , investigational device exemption ( IDE ) clinical study .</brief_summary>
	<brief_title>D2-EPG Study : Evaluation New Sensing Circuitry Capture Management</brief_title>
	<detailed_description>The purpose study confirm performance new sense circuitry , confirm performance Ventricular Capture Management feature subject implantable cardioverter defibrillator ( ICD ) lead connect external pacemaker/defibrillator .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<criteria>Patients schedule implantation replacement implantable cardioverter defibrillator ( ICD ) cardiac resynchronization therapy ( CRT ) device Patients must receive Medtronic transvenous atrial ventricular lead association schedule device implant replacement . Patients 3rd degree heart block , assess investigator Patients mechanical tricuspid heart valve Patients receive investigational new drug device , currently enrol clinical study new indication approve drug device</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2008</verification_date>
	<keyword>Sensing</keyword>
	<keyword>Capture Management</keyword>
	<keyword>Heart Failure</keyword>
	<keyword>ICD Indication</keyword>
</DOC>